Literature DB >> 2942543

Lec1A Chinese hamster ovary cell mutants appear to arise from a structural alteration in N-acetylglucosaminyltransferase I.

W Chaney, P Stanley.   

Abstract

The biochemical and kinetic properties of UDP-GlcNAc:alpha-D-mannoside (GlcNAc to Man alpha 1,3) beta 1,2-N-acetylglucosaminyltransferase I (GlcNAc-TI) have been investigated in the Chinese hamster ovary glycosylation mutant Lec1A. Previous studies showed that, whereas Lec1A cells synthesize complex carbohydrates at levels consistent with partial GlcNAc-TI action, no GlcNAc-TI activity was detected in Lec1A cell-free extracts (Stanley, P., and Chaney, W. (1985) Mol. Cell. Biol. 5, 1204-1211). It is now reported that, under altered reaction conditions, GlcNAc-TI activity can be measured in Lec1A cell extracts. The GlcNAc-TI enzyme in Lec1A.2C has a pH optimum of 7.5 (compared with 6.25 for the parental enzyme) and apparent Km values for Man5GlcNAc2Asn and UDP-GlcNAc that are, respectively, 21- and 44-fold higher than the apparent Km values of GlcNAc-TI from parental Chinese hamster ovary cells. Two independent Lec1A mutants possess GlcNAc-TI activities with similarly altered biochemical and kinetic properties. In fact, under optimal assay conditions for each cell line, the level of GlcNAc-TI in Lec1A extracts is equal to that of parental Chinese hamster ovary cell extracts. Interestingly, the two glycosylation sites of the G glycoprotein of vesicular stomatitis virus are processed quite differently in Lec1A cells. The glycopeptide nearest the carboxyl-terminal appears to be a preferred substrate for the Lec1A GlcNAc-TI activity. The combined data suggest that the Lec1A mutation affects the gene that codes for GlcNAc-TI, giving rise to a structurally altered glycosyltransferase with different biochemical properties.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942543

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

2.  Rapid assays for lectin toxicity and binding changes that reflect altered glycosylation in mammalian cells.

Authors:  Pamela Stanley; Subha Sundaram
Journal:  Curr Protoc Chem Biol       Date:  2014-06-03

3.  Substrate Specificities of N-Acetylglucosaminyl-, Fucosyl-, and Xylosyltransferases that Modify Glycoproteins in the Golgi Apparatus of Bean Cotyledons.

Authors:  K D Johnson; M J Chrispeels
Journal:  Plant Physiol       Date:  1987-08       Impact factor: 8.340

4.  Transfection of a human gene that corrects the Lec1 glycosylation defect: evidence for transfer of the structural gene for N-acetylglucosaminyltransferase I.

Authors:  R Kumar; P Stanley
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Molecular basis of N-acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N-glycans.

Authors:  Richard Strasser; Johannes Stadlmann; Barbara Svoboda; Friedrich Altmann; Josef Glössl; Lukas Mach
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

6.  Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation.

Authors:  R Kumar; J Yang; R D Larsen; P Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Fringe modulation of Jagged1-induced Notch signaling requires the action of beta 4galactosyltransferase-1.

Authors:  J Chen; D J Moloney; P Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

8.  Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates.

Authors:  E Ioffe; P Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Comparative therapeutic effects of velaglucerase alfa and imiglucerase in a Gaucher disease mouse model.

Authors:  You-Hai Xu; Ying Sun; Sonya Barnes; Gregory A Grabowski
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

10.  A testis-specific regulator of complex and hybrid N-glycan synthesis.

Authors:  Hung-Hsiang Huang; Pamela Stanley
Journal:  J Cell Biol       Date:  2010-08-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.